BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31398195)

  • 21. What is the NCD service capacity and disruptions due to COVID-19? Results from the WHO non-communicable disease country capacity survey in the Americas region.
    Luciani S; Caixeta R; Chavez C; Ondarsuhu D; Hennis A
    BMJ Open; 2023 Mar; 13(3):e070085. PubMed ID: 36863746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.
    McGettigan P; Henry D
    PLoS Med; 2013; 10(2):e1001388. PubMed ID: 23424288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
    Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
    BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in updating national guidelines and essential medicines lists in Sub-Saharan African countries to include WHO-recommended postpartum hemorrhage medicines.
    Ng'ang'a J; Chitimbe T; Mburu R; Rushwan S; Ntirushwa D; Chinery L; Gülmezoglu AM
    Int J Gynaecol Obstet; 2022 Jun; 158 Suppl 1(Suppl 1):11-13. PubMed ID: 35762803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patent and exclusivity status of essential medicines for non-communicable disease.
    Mackey TK; Liang BA
    PLoS One; 2012; 7(11):e51022. PubMed ID: 23226453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?
    Rowlands A; Acosta-Gualandri A; Guevara-Aguirre J; Chanoine JP
    BMJ Glob Health; 2016; 1(3):e000114. PubMed ID: 28588968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of essential medicines lists in 137 countries.
    Persaud N; Jiang M; Shaikh R; Bali A; Oronsaye E; Woods H; Drozdzal G; Rajakulasingam Y; Maraj D; Wadhawan S; Umali N; Wang R; McCall M; Aronson JK; Plüddemann A; Moja L; Magrini N; Heneghan C
    Bull World Health Organ; 2019 Jun; 97(6):394-404C. PubMed ID: 31210677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
    Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
    Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential medicines for emergency care in Africa.
    Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
    Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential medicines for reproductive health: developing evidence based interagency list.
    Logez S; Jayasekar S; Moller H; Ahmed K; Patel MU
    South Med Rev; 2011 Dec; 4(2):62-8. PubMed ID: 23093884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
    Bazargani YT; Ugurlu M; de Boer A; Leufkens HGM; Mantel-Teeuwisse AK
    BMC Cardiovasc Disord; 2018 Jun; 18(1):126. PubMed ID: 29940880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus.
    Babatunde D; Pollock AM; Ocan M; Brhlikova P
    JRSM Open; 2024 Mar; 15(3):20542704241232814. PubMed ID: 38560365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription of potentially inappropriate medicines and comparison with lists of essential medicines for treatment of chronic disorders in older patients.
    Gu J; Li SJ; Yu A; Xing Z; Kong J; Yang J; Wang YH
    Arch Gerontol Geriatr; 2023 Jun; 109():104939. PubMed ID: 36746015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
    Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
    Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Access to essential medicines to treat chronic respiratory disease in low-income countries.
    Bissell K; Perrin C; Beran D
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Availability, Costs and Stock-Outs of Essential NCD Drugs in Three Rural Rwandan Districts.
    Mukundiyukuri JP; Irakiza JJ; Nyirahabimana N; Ng'ang'a L; Park PH; Ngoga G; El-Khatib Z; Nditunze L; Dusengeyezu E; Rusangwa C; Mpunga T; Mubiligi J; Hedt-Gauthier B
    Ann Glob Health; 2020 Sep; 86(1):123. PubMed ID: 33024709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing Single-Pill Combination Therapy for Hypertension: A Scoping Review of Key Health System Requirements in 30 Low- and Middle-Income Countries.
    Bruyn E; Nguyen L; Schutte AE; Murphy A; Perel P; Webster R
    Glob Heart; 2022; 17(1):6. PubMed ID: 35174047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021.
    Kadyrova N; Gotham D; Kniazkov S; Aghayev E; Hajibalayev P; Ermatov Z; Azzopardi Muscat N
    PLoS One; 2023; 18(12):e0294680. PubMed ID: 38060531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How effective was implementation of the package of essential non-communicable disease (PEN) interventions: A review of evidence?
    Tripathy JP; Mishra S
    Diabetes Metab Syndr; 2021; 15(5):102266. PubMed ID: 34496339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.
    Onyango MA; Vian T; Hirsch I; Salvi DD; Laing R; Rockers PC; Ashigbie PG; Wirtz VJ
    PLoS One; 2018; 13(8):e0201917. PubMed ID: 30142218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.